ADDEX THERAPEUTICS LTD
ADXNNASDAQTrading Snapshot
- Day Range
- $5.71 – $5.85
- 52-Week Range
- $5.04 – $12.05
- Volume
- $4.02B
- Avg Volume
- $4.49B
- Shares Outstanding
- 1.2M
- Next Earnings
- Oct 9, 2026
Fundamentals Snapshot
- Annual Revenue
- $29,972
- Last Q Revenue
- $7,691
- P/E Ratio
- -0.8
- P/S Ratio
- 70.5x
- EPS (TTM)
- $-4.88
- Dividend Yield
- 0.00%
Why Investors Own ADXN
- ✓High-growth profile — revenue up +13.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 56% gross margin and 5% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ADDEX THERAPEUTICS LTD
Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Their core strategy involves identifying oral small-molecule allosteric modulators for G-protein coupled receptors. The company's key programs include Dipraglurant, an investigational treatment for Parkinson's disease levodopa-induced dyskinesia and dystonia; ADX71149, which is being developed for epilepsy and other unspecified CNS conditions; and GABAB PAM, a compound aimed at treating addiction. Addex Therapeutics has established licensing and collaboration agreements with significant partners, including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002 and based in Geneva, Switzerland, the company was initially known as Addex Pharmaceuticals Ltd before officially changing its name to Addex Therapeutics Ltd in March 2012.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. Adagio Medical Holdings (NASDAQ:ADGM) stock
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock rose 118.1% to $0.61 during Monday's after-market session. The market value of their outstanding shares is at $3.8 million. TransCode Therapeutics (NASDAQ:RNAZ)